A
Anders Wall
Researcher at Uppsala University
Publications - 79
Citations - 9063
Anders Wall is an academic researcher from Uppsala University. The author has contributed to research in topics: Alzheimer's disease & Pittsburgh compound B. The author has an hindex of 34, co-authored 79 publications receiving 8281 citations. Previous affiliations of Anders Wall include GE Healthcare & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E. Klunk,Henry Engler,Agneta Nordberg,Yanming Wang,G. Blomqvist,Daniel P. Holt,Mats Bergström,Irina Savitcheva,Guo Feng Huang,Sergio Estrada,Birgitta Ausén,Manik L. Debnath,Julien Barletta,Julie C. Price,Johan Sandell,Brian J. Lopresti,Anders Wall,Pernilla Koivisto,Gunnar Antoni,Chester A. Mathis,Bengt Långström +20 more
TL;DR: The results suggest that PET imaging with the novel tracer, PIB, can provide quantitative information on amyloid deposits in living subjects.
Journal ArticleDOI
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg,Henry Engler,Ove Almkvist,Ove Almkvist,Ove Almkvist,Gunnar Blomquist,Göran Hagman,Anders Wall,Anna Ringheim,Bengt Langstrom,Bengt Langstrom,Agneta Nordberg,Agneta Nordberg +12 more
TL;DR: Correlations were observed in the MCI patients between PIB retention and CSF Abeta(1-42), total Tau and episodic memory, respectively, and the P IB retention in MCI converters was comparable to AD patients.
Journal ArticleDOI
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Henry Engler,Anton Forsberg,Ove Almkvist,Gunnar Blomquist,Emma Larsson,Irina Savitcheva,Anders Wall,Anna Ringheim,Bengt Långström,Agneta Nordberg +9 more
TL;DR: Relatively stable PIB retention after 2 years of follow-up in patients with mild Alzheimer's disease suggests that amyloid deposition in the brain reaches a plateau by the early clinical stages of Alzheimer’s disease and therefore may precede a decline in rCMRGlc and cognition.
Journal ArticleDOI
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG
Stephen F. Carter,Michael Schöll,Ove Almkvist,Anders Wall,Henry Engler,Bengt Långström,Agneta Nordberg +6 more
TL;DR: Increased 11C-DED binding throughout the brain of the MCI 11C/PIB+ patients potentially suggests that astrocytosis is an early phenomenon in AD development.
Journal ArticleDOI
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease
Elena Rodriguez-Vieitez,Laure Saint-Aubert,Stephen F. Carter,Ove Almkvist,Ove Almkvist,Ove Almkvist,Karim Farid,Michael Schöll,Konstantinos Chiotis,Steinunn Thordardottir,Steinunn Thordardottir,Caroline Graff,Caroline Graff,Anders Wall,Bengt Långström,Agneta Nordberg,Agneta Nordberg +16 more
TL;DR: Rodriguez-Vieitez et al. as mentioned in this paper showed that progression of Alzheimer's disease in a longitudinal, multi-racer PET study showed that the relationship between pathophysiological processes in the disease remains largely unclear.